Stock data

太醫 (4126)

太醫 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$219.65M, up 3.0% from a year earlier. EPS over the last four quarters totals NT$5.98.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 太醫 in Insightr